SLS - SELLAS Life Sciences GAAP EPS of -$0.31 August, 10 2023 05:17 PM SELLAS Life Sciences Group Inc. 2023-08-10 17:17:09 ET SELLAS Life Sciences press release ( NASDAQ: SLS ): Q2 GAAP EPS of -$0.31. As of June 30, 2023, cash and cash equivalents totaled approximately $13.8 million. For further details see: SELLAS Life Sciences GAAP EPS of -$0.31